Alcohol‐Associated Liver Disease: East Versus West
Phunchai Charatcharoenwitthaya, Suthat Liangpunsakul, Teerha Piratvisuth – 24 May 2021
Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives
Claudia Pinto Marques Souza de Oliveira, Helma Pinchemel Cotrim, Marco Arrese – 24 May 2021
Barreras y limitaciones para el acceso al trasplante hepático en Latinoamérica
Wellington Andraus – 24 May 2021
NAFLD in Lean Asians
Mohammed Eslam, Fei Chen, Jacob George – 24 May 2021
Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
Tung‐Hung Su, Jia‐Horng Kao – 24 May 2021
Latinoamérica: en busca del mejor modelo predictivo de recurrencia del hepatocarcinoma después del trasplante
Federico Piñero, Aline Chagas, e ilka Boin – 24 May 2021
Prólogo: Una colaboración entre CLD y la Asociación Latinoamericana para el Estudio del Hígado (ALEH)
Mário G. Pessoa, Manuel Mendizábal – 24 May 2021
AASLD Deepens Commitment to Diversity, Equity, and Inclusion
Miguel Malespin, Elizabeth J. May, Lauren D. Nephew, Sonali Paul, Alexis McCary, Saikiran Kilaru, Nizar A. Mukhtar, Mohamed A. Hassan, Carla W. Brady – 23 May 2021
Toward Norepinephrine as a First‐Line Treatment for All Hospitalized Patients With Hepatorenal Syndrome
Cary H. Paine, Raimund H. Pichler, Laura Evans, Scott W. Biggins – 23 May 2021
AASLD Deepens Commitment to Diversity, Equity, and Inclusion
Miguel Malespin, Elizabeth J. May, Lauren D. Nephew, Sonali Paul, Alexis McCary, Saikiran Kilaru, Nizar A. Mukhtar, Mohamed A. Hassan, Carla W. Brady – 23 May 2021